We serve Chemical Name:1,3-Dibromo-5-methoxybenzene CAS:74137-36-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1,3-Dibromo-5-methoxybenzene
CAS.NO:74137-36-3
Synonyms:3,5-Dibromophenyl methyl ether;MFCD02258848;Benzene, 1,3-dibromo-5-methoxy-;1,3-Dibromo-5-methoxybenzene
Molecular Formula:C7H6Br2O
Molecular Weight:265.930
HS Code:2909309090
Physical and Chemical Properties:
Melting point:38-45ºC
Boiling point:249.7±20.0 °C at 760 mmHg
Density:1.8±0.1 g/cm3
Index of Refraction:1.577
PSA:9.23000
Exact Mass:263.878540
LogP:3.87
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2811 6.1/PG 3
Packing Group:
Contact us for information like 3,5-Dibromophenyl methyl ether chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,3-Dibromo-5-methoxybenzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,3-Dibromo-5-methoxybenzene Use and application,3,5-Dibromophenyl methyl ether technical grade,usp/ep/jp grade.
Related News: This includes chemical APIs. 1,3-Dibromo-5-methoxybenzene manufacturer Jo Soden, Co-managing Director of Retrogenix, said ��We look forward to working with Resonant to deconvolute the targets for their antibodies. Resonant��s innovative platform is delivering functional therapeutic candidates at rapid pace and we welcome the opportunity to identify the specific, biologically-relevant targets which will help progress these leads towards promising new therapies for patients with cancer.�� 1,3-Dibromo-5-methoxybenzene supplier Cost: Hedge prices of thick product lines + self-produced intermediates fluctuate, and sufficient supply of upstream raw materials can significantly promote the production of APIs. 1,3-Dibromo-5-methoxybenzene vendor Pharmaceutical intermediates: chemical raw materials or chemical products used in the process of pharmaceutical synthesis, are intermediate products in the process of producing APIs, and can be further processed into APIs. 1,3-Dibromo-5-methoxybenzene factory Jo Soden, Co-managing Director of Retrogenix, said ��We look forward to working with Resonant to deconvolute the targets for their antibodies. Resonant��s innovative platform is delivering functional therapeutic candidates at rapid pace and we welcome the opportunity to identify the specific, biologically-relevant targets which will help progress these leads towards promising new therapies for patients with cancer.��
